Freeflow Ventures hosted a discussion focused on portfolio company iuno. iuno leverages proteomics and AI to develop bespoke skincare products tailored to individual unique biology.
Their vision is to bring consumer scale proteomics to improve quality of life. Learn more about the company at https://iuno.bio/ The discussion kicks off with a presentation and introductory remarks from iuno Founder & CEO Anu Thubagere and Co-founder & Advisor Ashwin Gopinath. It is followed by Q&A with Freeflow and concludes with questions from the audience.
List of speakers:
- Anu Thubagere, Founder and CEO, iuno
- Ashwin Gopinath, Co-founder, iuno
- David Fleck, Founder and Managing Partner, Freeflow Ventures
- Kevin Barrett, Managing Partner, Freeflow Ventures
Other articles
October 30, 2024
Holoclara: Developing Allergic and Autoimmune Disease Relief by Using Worms
Holoclara is a Freeflow Fund One portfolio company that discovers, develops and…
October 10, 2024
Membrion: Solving for Wastewater Recovery
Membrion is a Freeflow Fund Two portfolio company led by Founder & CEO Greg…
September 25, 2024
Wild Microbes: Scaling New Bioproducts
Wild Microbes is a Freeflow Fund Two portfolio company founded by Tim Wannier…